1 Flavonoids Isolated from , an Underutilized Vegetable, Exert Monoamine A & B Inhibitory and Anti-inflammatory Effects and Their Structure-activity Relationship.

2 Shared Molecular Signatures Across Neurodegenerative Diseases and Herpes Virus Infections Highlights Potential Mechanisms for Maladaptive Innate Immune Responses.

3 Application of native mass spectrometry in studying intrinsically disordered proteins: A special focus on neurodegenerative diseases.

4 Recent advances of induced pluripotent stem cells application in neurodegenerative diseases

5 Literature Evidence and ARRIVE Assessment on Neuroprotective Effects of Flavonols in Neurodegenerative Diseases' Models.

6 Cell death assays for neurodegenerative disease drug discovery

7 Copy Number Variations in the Survival Motor Neuron Genes: Implications for Spinal Muscular Atrophy and Other Neurodegenerative Diseases

8 An IoT Based Architecture for Enhancing the Effectiveness of Prototype Medical Instruments Applied to Neurodegenerative Disease Diagnosis.

9 Age-related neurodegenerative diseases.

10 Neuronal Sigma-1 Receptors: Signaling Functions and Protective Roles in Neurodegenerative Diseases.

11 Preimplantation genetic diagnosis of neurodegenerative diseases: Review of methodologies and report of our experience as a regional reference laboratory

12 Tracking the progression of social cognition in neurodegenerative disorders.

13 Phosphatidylserine Ameliorates Neurodegenerative Symptoms and Enhances Axonal Transport in a Mouse Model of Familial Dysautonomia.

14 Differential neurodegenerative phenotypes are associated with heterogeneous voiding dysfunction in a coronavirus-induced model of multiple sclerosis.

15 Ubiquitin Ligase LRSAM1 Suppresses Neurodegenerative Diseases Linked Aberrant Proteins Induced Cell Death.

16 Neural Stem Cell Transplantation for Neurodegenerative Diseases

17 Olfactory bulb involvement in neurodegenerative diseases

18 Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders

19 Homeostatic responses by surviving cortical pyramidal cells in neurodegenerative tauopathy

20 tau protein- induced sequestration of the eukaryotic ribosome: implications in neurodegenerative disease

21 cyclodextrins as emerging therapeutic tools in the treatment of cholesterol-associated vascular and neurodegenerative diseases

22 patient-derived ipscs and ins—shedding new light on the cellular etiology of neurodegenerative diseases

23 neurotoxic agent-induced injury in neurodegenerative disease model: focus on involvement of glutamate receptors

24 molecular diagnostics of neurodegenerative disorders

25 amylin at the interface between metabolic and neurodegenerative disorders

26 role of sex hormones on brain mitochondrial function, with special reference to aging and neurodegenerative diseases

27 stem cells for the treatment of neurodegenerative diseases

28 biometals in rare neurodegenerative disorders of childhood

29 stem cell treatment for age-related neurodegenerative diseases

30 the potential of epigenetic therapies in neurodegenerative diseases

31 neurobehavioral changes and activation of neurodegenerative apoptosis on long-term consumption of aspartame in the rat brain

32 dysregulation of the hpa axis as a core pathophysiology mediating co-morbid depression in neurodegenerative diseases

33 recent advances in studies on the therapeutic potential of dietary carotenoids in neurodegenerative diseases

34 lipid involvement in neurodegenerative diseases of the motor system: insights from lysosomal storage diseases

35 potential role of olive oil phenolic compounds in the prevention of neurodegenerative diseases

36 Medicinal plants for diabetes associated neurodegenerative diseases: A systematic review of preclinical studies.

37 behavioral impact of the regulation of the brain 2-oxoglutarate dehydrogenase complex by synthetic phosphonate analog of 2-oxoglutarate: implications into the role of the complex in neurodegenerative diseases

38 is modulation of oxidative stress an answer? the state of the art of redox therapeutic actions in neurodegenerative diseases

39 resveratrol: a focus on several neurodegenerative diseases

40 the involvement of micrornas in neurodegenerative diseases

41 neuroimaging in neurodegenerative dementias*

42 implications of glial nitric oxyde in neurodegenerative diseases

43 clinico-pathological correlations of the most common neurodegenerative dementias

44 editorial note. golgi pathology in neurodegenerative diseases.

45 a neural network underlying intentional emotional facial expression in neurodegenerative disease

46 redox status and aging link in neurodegenerative diseases 2015

47 role of brain glutamic acid metabolism changes in neurodegenerative pathologies

48 nutraceutical potential of phenolics from ′brava′ and ′mansa′ extra-virgin olive oils on the inhibition of enzymes associated to neurodegenerative disorders in comparison with those of ′picual′ and ′cornicabra′

49 liposomes for targeted delivery of active agents against neurodegenerative diseases (alzheimer's disease and parkinson's disease)

50 loss of neuroprotective factors in neurodegenerative dementias: the end or the starting point?

51 editorial: microglial polarization in the pathogenesis and therapeutics of neurodegenerative diseases

52 advancing stem cell models of alpha-synuclein gene regulation in neurodegenerative disease

53 regulatory roles of long non-coding rnas in the central nervous system and associated neurodegenerative diseases

54 the ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution

55 from prion diseases to prion-like propagation mechanisms of neurodegenerative diseases

56 coenzyme q10 effects in neurodegenerative disease

57 evidence for prion-like mechanisms in several neurodegenerative diseases: potential implications for immunotherapy

58 histone deacetylase inhibitor alleviates the neurodegenerative phenotypes and histone dysregulation in presenilins-deficient mice

59 parkin regulation and neurodegenerative disorders

60 Self-awareness in neurodegenerative disease relies on neural structures mediating reward-driven attention

61 Medicinal plants for anti-neurodegenerative diseases in West Africa.

62 Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers

63 Targeting Mitochondrial Dysfunction in Microglia: A New Frontier for Treating Neurodegenerative Diseases.

Keyword Connections

Journals

Research Groups

Bibliographies